Nonalcoholic Steatohepatitis Clinical Trials and Studies: EMA, PDMA, FDA Approvals ...
Promising Nonalcoholic Steatohepatitis Therapies such as AZD2693, Saroglitazar Magnesium 4 mg, Semaglutide (SEMA), Cilofexor ...
Nature2 个月
Antidiabetes wars: a new hope
The discovery of the nuclear receptor PPAR-γ as the molecular target of TZDs suggested a mechanism for their beneficial effects on insulin action. As PPAR-γ is mainly expressed in fat cells ...